On Focus

Founder and CEO of PxHealth Anne Bruinvels joins OnFocus to discuss the launch of OWise Prostate, a digital app designed to support men with prostate cancer.

https://owise.uk/prostate/

Former TFTC patient Delroy Wright joins On Focus to discuss his experience with prostate cancer, and to suggest some actions to both men and their doctors about testing and treatment.

Continence Nurse specialist Jane Simpson, author of the Pelvic Floor Bible, joins On Focus to discuss what men with prostate cancer need to know about continence and what they can do about it.

The Pelvic Floor Bible is available here:

https://www.amazon.co.uk/Pelvic-Floor-Bible-Everything-Problems/dp/0241386535

Consultant Urologist Tim Dudderidge joins On Focus to discuss what factors contribute to a patient’s recovery from prostate cancer treatment, and how this varies across treatment options.

He refers to a recent study of patient recovery from focal therapy, evaluated as functional outcomes

https://pubmed.ncbi.nlm.nih.gov/31971335/

Elvin Box, a popular and passionate advocate for men with prostate cancer joins On Focus to discuss learnings from his experience and how he’s taking these forward to improve the experience of others. Diagnosed in 2016, Elvin is a Movember UK ambassador and has written and campaigned extensively on a number of issues impacting men and their families as they experience a diagnosis of prostate cancer and navigate treatment options.

See recent publications from Elvin here:

https://metro.co.uk/2020/02/29/kept-cancer-diagnosis-secret-12316187/?ito=article.desktop.share.top.link

https://www.jodivine.com/blogs/perspectives/winning-back-our-sex-life-after-prostate-cancer-a-personal-story-by-elvin-box

Lorraine Grover, a Psychosexual Nurse Specialist, joins On Focus to discuss how a prostate cancer diagnosis and treatment impacts sexual identity and sexual relationships. For over 25 years Lorraine has been a passionate driver in helping to improve the way sexuality and sexual function is managed within healthcare. She has expertise in managing male sexual dysfunction and has a special interest in caring for patients diagnosed with prostate cancer (and whenever possible their partners). Sexual difficulties can have both psychological and organic causes and she is able to consider both aspects of management.

Learn more about Lorraine Grover here:

https://www.lorrainegrover.com/about-lorraine-grover

Tony Collier, ambassador, awareness speaker and fundraiser for Prostate Cancer UK, joins On Focus to to share his views on exercise for men with a prostate cancer diagnosis, borne out of his personal experience as a dedicated runner and that of his many supporters and followers on social media.

Dr Asanga Fernando, Consultant Cancer Liaison Psychiatrist and Clinical Director of the Advanced Patient Simulation and Clinical Skills Centre at St George’s University Hospitals NHS Trust, London, joins OnFocus to discuss his work on integrating mental health support with prostate cancer care.

Dr Sam Merriel joins On Focus to discuss how GPs are supporting men in their prostate health and explores some avenues for improvement. Dr Merriel is a GP practicing in North Somerset in SouthWest England. He is also a clinical senior research fellow at the University of Exeter, investigating ways of improving the early diagnosis of cancer in primary care. He has published research on prostate cancer diagnosis and management, and his current Cancer Research UK funded research is exploring the potential of GPs using prostate MRI to aid in the early and accurate diagnosis of prostate cancer.

Alan Doherty, Clinical Director at the Birmingham Prostate Clinic, and recently voted one of the UK’s top ten prostate cancer specialists in a national poll of consultant urologists published in the Daily Mail, joins OnFocus to discuss the recently published study led by Imperial College comparing outcomes of men undergoing focal therapy and radical prostatectomy. Alan has been an innovator, advocate and dedicated practitioner of precision treatments for prostate cancer, and thinks the study’s real impact will be felt amongst men considering Active Surveillance.